HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 68714946, compound → HCID 57994383, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 68714946 | HCID 68714946 | — |
| Reactant | HCID 178418348 | HCID 178418348 | — |
| Catalyst | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| Catalyst | HCID 91886321 | HCID 91886321 | — |
| Catalyst | HCID 178418476 | HCID 178418476 | — |
| Product | HCID 57994383 | HCID 57994383 | 70% |
Reaction Steps
9-Methoxy-7-methyl-4-trifluoromethanesulfonyl-5H-furo[3,2-g]chromen-5-one (324 mg, 1.0 mmol), ZnBr2.H2O (1.04 g, 4.0 mmol), CuI (28 mg, 0.15 mmol), PdCl2(PPh3)2 (84 mg, 0.12 mmol) and MeLi (2.5 ml of 1.6 M in diethylether, 4.0 mmol) were treated as described under General Procedure G (Step 2) to afford the title compound (Yield 70%). 1H NMR (300 MHz, CDCl3): δ 2.38 (s, 3H, Me), 2.94 (s, 3H, Me), 4.21 (s, 3H, OMe), 6.05 (s, 1H), 6.91 (d, J=2.4, 1H), 7.65 (d, J=2.4, 1H). MS (ES) m/z: 244.9 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08309545B2 |
| Source dataset | uspto-grants-2012_11 |
| ORD ID | ord-d0cbebc808154bd78e1a199c5abde9d7 |
| Source note | uspto-grants-2012_11 |